Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer
NCT01969955
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Squamous Cell Carcinoma of Lung
Interventions
DRUG:
nanoparticle albumin-bound paclitaxel
Sponsor
Chinese Academy of Medical Sciences